Category: | Medical & Pharma, Oncology |
---|---|
Organizer: | European Association for Cancer Research |
Exhibition center: | Centro Congressi Giovanni XXIII |
Hotels search near to Centro Congressi Giovanni XXIII
Overview interest facts - EACR-ESMO Joint Conference on Liquid Biopsies 2022
EACR-ESMO Joint Conference on Liquid Biopsies 2022 aims to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse.
Recommended events
Find airticket to EACR-ESMO Joint Conference on Liquid Biopsies 2022
Recommended events
News
New material improves treatment of complex bone infections
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...
29 November 2023Cellular Mechanics-Based Tool May Help Diagnose Cancerous Cells
A team lead by researchers from the National Institute for Materials Science (NIMS) in Tsukuba, Japan, used atomic force microscopy to apply force across the surface o...
24 November 2023Sepsis - as common as cancer, as deadly as a heart attack
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.
04 September 2023New blood test finds two thirds of cancers
A new multi-cancer early detection blood test could speed up diagnosis.
16 June 2023Fast, Cheap, and Easy Testing Method Could Become a Game-Changer in Antibiotic Sensitivity Testing
Antibiotic resistance, which has become a critical global public health issue, occurs when bacteria evolve to withstand the drugs designed to eliminate them.
01 May 2023Researchers have developed a revolutionary new bone cancer treatment
Researchers from the University of East Anglia (UEA) have developed a new, non-invasive bone cancer treatment that is effective against all primary forms of the diseas...
04 April 2023